Enjoy the reading: To view or add a comment, sign in Peptide Therapies for Neurological Disorders | Alzheimers & Parkinsons Peptide-based therapies are gaining growing attention in neurological research, offering innovative possibilities for conditions like Alzheimers disease, Parkinsons disease, and other neurodegenerative disorders
MDD has a lifetime prevalence of 12% and is a leading cause of global disability (Filatova et al
Zinc and copper are also important cofactors in collagen formation
Undenatured whey protein is another good source of cysteine and glutamine, assisting in the production of glutathione
To do this, they created a sort of evil FOXO4 twin called a FOXO4-DRI peptide it looked and acted like FOXO4 from a chemical perspective (in fact, p53 liked to bind with FOXO4-DRI even more than regular FOXO4, which is important because of some complicated chemistry), but FOXO4-DRI didnt only live in the nucleus it could exist anywhere in the cell
This change to the structure extends the half-life to about 170 to 180 hours, which allows for dosing once a week